VANCOUVER — Vancouver-based Pivot Pharmaceuticals Inc. has begun development of CBD and THC additives and formulations for the beverage industry.
The product development utilizes Pivot’s patented Ready-To-Infuse-Cannabis (RTIC) Powder and Solmic Micelle water-soluble technologies and will be led by the company’s executive director of Formulations, Dr. Leonid Lurya, at the Company’s contract lab in Israel.
“Pivot will bring cannabis derivatives to market that are differentiated and backed by science,” says Dr. Patrick Frankham, Pivot’s CEO. “The beverage market opportunity is just too big to ignore and our patented technologies lend themselves well to this space. Existing solutions are unable to provide consistent dosing nor offer the most effective bioavailability, which our patented technology is able to remedy.”
Pivot aims to bring finished additives to market that will include bulk cannabis powder for infusion into beverages by multi-national beverage companies and craft brewers interested in entering the massive cannabis market.
“It is our intention to supply CBD and THC additives as ingredients for global wine, spirits, beer and energy drink companies who have the capabilities for large scale manufacturing and distribution,” adds Frankham.
The company is also currently developing cannabis in a single-use powder formula sachet and a water-soluble liquid solution in a concentrated dropper bottle that consumers can add to their favourite beverage. The new products are being developed to be flavourless, odourless and compliment the consumer’s intended beverage experience.